Gilead Presents Real-World and Long-Term Data From HIV Resea

– New Clinical and Patient-Reported Outcomes in People with HIV on Biktarvy® in Observational BICSTaR Study Demonstrate Consistent Efficacy Profile in Real-World Setting –

–... | October 18, 2022

Related Keywords

Norway , California , United States , Iceland , Glasgow , Glasgow City , United Kingdom , Liechtenstein , Foster City , Scotland , Jared Baeten , Gilead Sciences , Gilead Sciences Inc , Nasdaq , Exchange Commission , European Union , European Medicines Agency , Cure Research , Treatment Research , Clinical Development , International Congress On Drug Therapy , International Congress , Drug Therapy , Vice President , Transformational Innovation , Important Safety Information , Boxed Warnings , European Marketing Authorization , Product Characteristics , Safety Information , Drug Interactions , Antiretroviral Pregnancy Registry , Funders Concerned About , Private Securities Litigation Reform Act , Quarterly Report , Prescribing Information , Nc Stock Exchange , News , Information , Press Release , Few , Linical , End , Outcomes , N , People , Ith , Shiv , Observational , Icstar , Study , Emonstrate , Consistent , Efficacy , Profile , Etting Gild Us3755581036 ,